title: Determination of the optimal concentration of several selective drugs useful for generating multi-transgenic porcine embryonic fibroblasts.
abstract: Porcine embryonic fibroblasts (PEFs) are widely used as donor cells for somatic cell nuclear transfer (SCNT) in pigs. Transfection of PEFs with exogenous DNA is essential for producing genetically modified (GM; transgenic or knockout) pigs via SCNT. In this case, selectable markers are strictly required selecting and enriching stably transfected cells. The most frequently used selective drug for this purpose is a neomycin analogue (G418/geneticin); neo has been widely used as a selectable marker gene in the genomic manipulation of pigs. However, little is known about optimal concentrations of other selection drugs. This often hampers functional analysis of the porcine genome and development of individual GM pigs. This study explores the optimal concentrations of selective drugs, other than neomycin, that can be used for the selection of transfected PEFs. Porcine embryonic fibroblasts were incubated in media containing different concentrations of drugs for up to 10 days, to determine the optimal drug concentrations fatal for PEFs. The following concentrations were found to be optimal selective concentrations for use with PEFs: G418/geneticin, 400 μg/ml; blasticidin S, 8 μg/ml; hygromycin B, 40 μg/ml; puromycin, 2 μg/ml; and zeocin, 800 μg/ml. Repeated transfections with plasmids carrying selectable markers resulted in the generation of multidrug-resistant swine transfectants. Furthermore, these markers were found to be independent. The present information will be useful for the production of SCNT-mediated GM piglets that express multiple transgenes.
authors.affiliation: Section of Gene Expression Regulation, Frontier Science Research Center, Kagoshima University, Kagoshima, Japan. masasato@ms.kagoshima-u.ac.jp
authors.forename: M
authors.initials: M
authors.lastname: Sato
authors.forename: M
authors.initials: M
authors.lastname: Ohtsuka
authors.forename: H
authors.initials: H
authors.lastname: Miura
authors.forename: K
authors.initials: K
authors.lastname: Miyoshi
authors.forename: S
authors.initials: S
authors.lastname: Watanabe
mesh_terms: D000123:Acetyltransferases / Q000235:genetics; D000818:Animals; D030801:Animals, Genetically Modified / Q000196:embryology*; D001761:Bleomycin / Q000494:pharmacology; D016923:Cell Death / Q000187:drug effects; D004247:DNA / Q000032:analysis; D004351:Drug Resistance / Q000235:genetics; D005260:Female; D005347:Fibroblasts / Q000187:drug effects / Q000648:ultrastructure*; D005819:Genetic Markers; D005839:Gentamicins / Q000494:pharmacology; D005865:Gestational Age; D049452:Green Fluorescent Proteins / Q000235:genetics; D006921:Hygromycin B / Q000494:pharmacology; D053652:Nuclear Transfer Techniques / Q000662:veterinary*; D009705:Nucleosides / Q000494:pharmacology; D011691:Puromycin / Q000494:pharmacology; D013552:Swine; D013556:Swine, Miniature / Q000196:embryology* / Q000235:genetics; D014162:Transfection; D019076:Transgenes / Q000235:genetics
chemical_list: D005819:Genetic Markers; D005839:Gentamicins; D009705:Nucleosides; C485184:enhanced green fluorescent protein; D001761:Bleomycin; D049452:Green Fluorescent Proteins; C105427:Zeocin; D006921:Hygromycin B; D011691:Puromycin; C004500:blasticidin S; D004247:DNA; C010680:antibiotic G 418; D000123:Acetyltransferases; C045336:puromycin N-acetyltransferase